OU Health Stephenson Cancer Center joins extensive network of leading Caris cancer facilities committed to leveraging clinical data to advance patient care and outcomes
Irving, Texas, August 10, 2022 /PRNewswire/ — Karis Life Sciences®(Caris), a leading molecular science and technology company actively developing and delivering innovative solutions that revolutionize healthcare, today announced that OU Health Stephenson Cancer Center has joined the Caris Precision Oncology Alliance™ (POA) announced that it had participated in POA is a growing network of leading cancer centers worldwide working together to advance precision oncology and biomarker-driven research. POA members collaborate to establish and optimize the standard of care for molecular testing through innovative research focused on predictive and prognostic markers that improve clinical outcomes for cancer patients.
located in University of Oklahoma Health Science Center the campus of oklahoma cityStevenson Cancer Center is the state’s only National Cancer Institute (NCI)-designated cancer center and provides an important resource for patients seeking research-driven, patient-centered, multidisciplinary care.Named oklahoma The best facility for cancer treatment US News & World Report In the 2020-21 rankings, Stevenson Cancer Center also ranked first among all cancer centers in the nation for the number of people participating in NCI-sponsored clinical trials.
“Stevenson Cancer Center is delighted to join the Carris Precision Oncology Alliance. Kathleen Moore, MD, Professor of Gynecologic Oncology, Virginia Kerley Cade Cancer Development and Therapeutics Endowed Chair, and Director of the Oklahoma TSET Phase 1 Program. “With this partnership, our mission is to identify potential target biomarkers using a new and innovative platform to contribute to groundbreaking research that will improve the lives of all cancer patients. can move forward.”
Stevensen Cancer Center Committed to Reducing the Harmful Effects of Cancer Oklahoma And while training the next generation of cancer researchers and health professionals, it will have a profound impact on underserved populations across the state. Stevenson Cancer Center’s dedicated program for cancer research supports his 135 investigators who study the basic, clinical, and behavioral sciences relevant to cancer treatment.
“We are delighted to welcome OU Health Stephenson Cancer Center to the growing Precision Oncology Alliance network. Chadi Naban, MD, MBA, FACP, Chairman of the Carris Precision Oncology Alliance. “The ability to collaborate with clinicians and researchers at Stevenson Cancer Center to conduct cutting-edge precision oncology research is destined to help improve outcomes for cancer patients and is consistent with the vision of both organizations. increase.”
“Understanding the molecular basis of all cancers will help match the right patients to the right clinical trials, and may lead to better treatment strategies across all tumor types,” he said. Abdul Rafe Nakash, MD, Assistant Professor of Medicine and Clinical/Translational Investigator in the TSET Phase 1 Program at Stevenson Cancer Center. “We look forward to joining his POA network and contributing meaningful research ideas in this collaboration.”
The Caris Precision Oncology Alliance includes 70 cancer centers and academic institutions. These institutions have early access to the extensive database and artificial intelligence platform within Caris to establish evidence-based standards for cancer profiling and molecular testing in oncology. Leveraging the comprehensive genomic, transcriptomic and proteomic profiling available through Caris molecular profiling, Caris will help this network prioritize therapeutic options and identify which clinical trial opportunities will benefit patients. It seeks to provide the ability to judge. POA members can also integrate a portfolio of biomarker-oriented studies sponsored by biopharmaceuticals. Additionally, as a POA member, the institution has access to his Caris CODEai™. Caris CODEai™ is the industry’s most comprehensive data solution with cancer treatment information and clinical outcome data for over 275,000 patients covering over 1 million data points per patient.
About Calis Life Science
Caris Life Sciences® (Caris) is a leading molecular science and technology company that actively develops and delivers innovative solutions to revolutionize healthcare and improve patient outcomes. Through comprehensive molecular profiling (whole-exome and whole-transcriptome sequencing) and the application of advanced artificial intelligence (AI) and machine learning algorithms, Caris provides the large-scale research needed to analyze and unravel molecular complexity. created a comprehensive clinical genome database and cognitive computing. disease. This information is unique for conducting fundamental and foundational research to accelerate discovery for detection, diagnosis, monitoring, treatment selection, and drug development to improve the human condition. Provides resources and ideal pathways.
Caris’ market-leading suite of molecular profiling services, primarily focused on cancer, evaluates DNA, RNA, and protein to help patients, physicians, and researchers better detect, diagnose, and treat their patients. Reveal a molecular blueprint that helps Caris’ latest advancement is the blood-based circulating nucleic acid sequencing (cNAS) assay, which combines comprehensive molecular analysis (whole-exome and whole-transcriptome sequencing from blood) with continuous monitoring, It is the most powerful liquid biopsy assay ever developed.
Head office location Irving, TexasKallis has an office in Phoenix, New York, Denver, Tokyo Japan When Basel, SwitzerlandCaris offers services nationwide, Europe, Asia and other international markets. For more information, visit CarisLifeSciences.com or follow us on Twitter at@CarisLS).
about OU Health Stevenson Cancer Center
OU Health Stephenson Cancer Center oklahoma National Cancer Center designated cancer centers only. Stephenson Cancer Center is he one of the elite centers in the United States, representing the top 2% of cancer centers in the country. It is the state’s largest and most comprehensive oncology clinic, providing patient-centered, multidisciplinary care for all types of cancer. As one of the nation’s leading research institutions, Stevenson Cancer Center utilizes the latest innovations to fight and eradicate cancer and is now part of NCI’s National Clinical Trials Network. For more information, visit stephensoncancercenter.org.
Caris Life Sciences media contact:
Lisa Bergner
[email protected]
469.822.9330
OU Health Stevenson Cancer Center Media contact:
April Sandefer
Director of Communications, OU Health
[email protected]
405.323.8552
Source: Caris Life Sciences
